Aurora Casanova

1.4k total citations
27 papers, 929 citations indexed

About

Aurora Casanova is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Aurora Casanova has authored 27 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 8 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Aurora Casanova's work include Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (5 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). Aurora Casanova is often cited by papers focused on Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (5 papers) and Botulinum Toxin and Related Neurological Disorders (4 papers). Aurora Casanova collaborates with scholars based in Spain, United States and Switzerland. Aurora Casanova's co-authors include Javier Ariza, Francesc Gudiol, Ramón Díaz, Jordi Carratalà, Beatriz Rosón, Jordi Dorca, Frederic Manresa, Ignacio Moriyón, Miguel Santín and Ferrán Bolao and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and International Journal of Cancer.

In The Last Decade

Aurora Casanova

27 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurora Casanova Spain 15 607 285 165 145 126 27 929
Celal Ayaz Türkiye 17 401 0.7× 222 0.8× 109 0.7× 136 0.9× 194 1.5× 61 850
Paloma Geijo Spain 12 338 0.6× 308 1.1× 51 0.3× 77 0.5× 160 1.3× 20 566
Mustafa Namıduru Türkiye 13 286 0.5× 236 0.8× 43 0.3× 60 0.4× 98 0.8× 54 598
Alastair McGregor United Kingdom 14 166 0.3× 174 0.6× 35 0.2× 29 0.2× 203 1.6× 27 762
Hasan Salih Zeki Aksu Türkiye 12 253 0.4× 150 0.5× 21 0.1× 31 0.2× 80 0.6× 39 503
Yaşar Bayındır Türkiye 13 158 0.3× 78 0.3× 59 0.4× 22 0.2× 95 0.8× 71 478
Richard E. Winn United States 16 382 0.6× 125 0.4× 26 0.2× 26 0.2× 388 3.1× 51 875
Jong‐Min Chen Taiwan 19 660 1.1× 67 0.2× 39 0.2× 17 0.1× 297 2.4× 45 1.0k
Nurgül Ceran Türkiye 15 239 0.4× 90 0.3× 43 0.3× 24 0.2× 142 1.1× 28 503
Glenn R. Hodges United States 16 311 0.5× 46 0.2× 30 0.2× 24 0.2× 175 1.4× 44 807

Countries citing papers authored by Aurora Casanova

Since Specialization
Citations

This map shows the geographic impact of Aurora Casanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurora Casanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurora Casanova more than expected).

Fields of papers citing papers by Aurora Casanova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurora Casanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurora Casanova. The network helps show where Aurora Casanova may publish in the future.

Co-authorship network of co-authors of Aurora Casanova

This figure shows the co-authorship network connecting the top 25 collaborators of Aurora Casanova. A scholar is included among the top collaborators of Aurora Casanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurora Casanova. Aurora Casanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Díaz, Ramón, Aurora Casanova, Javier Ariza, & Ignacio Moriyón. (2011). The Rose Bengal Test in Human Brucellosis: A Neglected Test for the Diagnosis of a Neglected Disease. PLoS neglected tropical diseases. 5(4). e950–e950. 163 indexed citations
2.
González, Victoria, Miquel Granell, Lurdes Matas, et al.. (2008). Recently acquired HIV infection in Spain (2003-2005): introduction of the serological testing algorithm for recent HIV seroconversion. Sexually Transmitted Infections. 85(2). 106–110. 13 indexed citations
3.
Casanovas-Taltavull, Teresa, Carme Baliellas, Josep M. Cruzado, et al.. (2007). Preliminary Results of Treatment With Pegylated Interferon Alpha 2A for Chronic Hepatitis C Virus in Kidney Transplant Candidates on Hemodialysis. Transplantation Proceedings. 39(7). 2125–2127. 23 indexed citations
4.
Santín, Miguel, M Mestre, Evelyn Shaw, et al.. (2007). Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease. European Journal of Clinical Microbiology & Infectious Diseases. 27(1). 65–73. 16 indexed citations
5.
Santín, Miguel, Evelyn Shaw, Rossella Rota, et al.. (2006). Efficacy and Safety of Pegylated Interferon- α 2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in HIV-Infected Patients. AIDS Research and Human Retroviruses. 22(4). 315–320. 13 indexed citations
6.
Díaz, Ramón, et al.. (2006). Secondary Serological Response of Patients with Chronic Hepatosplenic Suppurative Brucellosis. Clinical and Vaccine Immunology. 13(11). 1190–1196. 14 indexed citations
7.
Ribes, Josepa, Ramón Clèries, Roberto Mazzara, et al.. (2006). Cofactors associated with liver disease mortality in an HBsAg‐positive Mediterranean cohort: 20 years of follow‐up. International Journal of Cancer. 119(3). 687–694. 36 indexed citations
9.
Casanovas-Taltavull, Teresa, Carme Baliellas, C Benasco, et al.. (2001). Efficacy of Interferon for Chronic Hepatitis C Virus–Related Hepatitis in Kidney Transplant Candidates on Hemodialysis: Results After Transplantation. The American Journal of Gastroenterology. 96(4). 1170–1177. 24 indexed citations
10.
Ariza, Javier, Carlos Pigrau, Carlos A. Cañas, et al.. (2001). Current Understanding and Management of Chronic Hepatosplenic Suppurative Brucellosis. Clinical Infectious Diseases. 32(7). 1024–1033. 95 indexed citations
11.
Rosón, Beatriz, Jordi Carratalà, Jordi Dorca, et al.. (2001). Etiology, Reasons for Hospitalization, Risk Classes, and Outcomes of Community‐Acquired Pneumonia in Patients Hospitalized on the Basis of Conventional Admission Criteria. Clinical Infectious Diseases. 33(2). 158–165. 225 indexed citations
12.
Rosón, Beatriz, José L. Pérez, R. Verdaguer, et al.. (1999). Usefulness of PCR and Antigen Latex Agglutination Test with Samples Obtained by Transthoracic Needle Aspiration for Diagnosis of Pneumococcal Pneumonia. Journal of Clinical Microbiology. 37(3). 709–714. 43 indexed citations
13.
Herreros, Judit, Eulàlia Martı́, Bonaventura Ruiz-Montasell, et al.. (1997). Localization of Putative Receptors for Tetanus Toxin and Botulinum Neurotoxin Type A in Rat Central Nervous System. European Journal of Neuroscience. 9(12). 2677–2686. 6 indexed citations
14.
Baliellas, Carme, Eva Sesé, Marisa Iborra, et al.. (1995). Interferon may be useful in hemodialysis patients with hepatitis C virus chronic infection who are candidates for kidney transplant.. PubMed. 27(4). 2229–30. 25 indexed citations
15.
Cánaves, Jaume M., Mònica Arribas, Aurora Casanova, et al.. (1995). Botulinum toxin type A inhibits Ca2+-dependent transport of acetylcholine in reconstituted giant liposomes made from presynaptic membranes from cholinergic nerve terminals. Neuroscience Letters. 196(1-2). 37–40. 9 indexed citations
17.
Podzamczer, D, et al.. (1993). Low‐dose interferon alpha combined with zidovudine in patients with AIDS‐associated Kaposi's sarcoma. Journal of Internal Medicine. 233(3). 247–253. 27 indexed citations
19.
Marsal, Jordi, et al.. (1987). Depolarization-induced release of ATP from cholinergic synaptosomes is not blocked by botulinum toxin type A. Neurochemistry International. 10(3). 295–302. 24 indexed citations
20.
Rufı́, G, et al.. (1986). [Bacterial meningitis. Etiology and focus of origin of 482 episodes].. PubMed. 86(15). 615–20. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026